Implementation deadlines

IMPLEMENTATION SCHEDULE

 

 

  • June 2016 : For new marketing authorization

​​​

 

  • December 2017 : For products already marketed

 

 

 

CURRENT REGULATION

The ICH Q3D guideline comes into effect in the three pharmacopeias (Europe, US and Japan).                                                                                                                                                                                                             

USP -232- ELEMENTAL IMPURITIES LIMITS 
USP -233- ELEMENTAL IMPURITIES PROCEDURES

JP 1.07 "HEAVY METALS LIMIT TEST"
PH. EUR: 5.20, 2.4.20, 2.4.8

 

 

 

To fullfill ICH Q3D requirements before this deadlines expired, we develop Elemental Impurities Implementation of Risk Assessment Reports, for both API manufacturers and drug product manufacturers. You can contact us regarding a QUOTATION REQUEST for an ICH Q3D report development.

Latest news

Back to physical CPhI 2021

SOCOSUR WILL BE BACK TO CPHI WITH BOOTH LOCATED 14B61   CPhI Worldwide houses six...(...)

A3P Cosmetics Symposium 2021

Back to face to face events for Socosur. We will attend A3P Cosmetics symposium 2021 with a...(...)

A3P Cleaning Validation Symposium

Next June 29th and 30th 2021, Socosur Tox will exhibit at the second edition of the A3P Cleaning...(...)

HydroxyChloroquine Sulfate free of charge PDE and OEL monographs to support the fight versus Covid-19

As responsible player in the European healthcare system, we have organized ourselves to meet our...(...)

Stay in touch